Zusammenfassung
Es werden nichtinfektiöse entzündliche Dermatosen mit überwiegend neutrophilen Infiltraten sowie pustulöse Dermatosen beschrieben, deren Infiltratdichte von spärlich (bei der Urtikaria) bis sehr dicht mit Leukozytoklasie (z. B. Sweet-Syndrom oder Pyoderma gangraenosum) variiert. Neutrophile Dermatosen werden durch diverse nichtinfektiöse Immunmechanismen ausgelöst. In den letzten Jahren wurden zudem vermehrt ursächliche Mutationen entdeckt (z. B. NLRC4-Mutation bei Cryopyrin-assoziierten periodischen Fiebersyndromen [CAPS] und anderen autoinflammatorischen Syndromen; IL36RN-Mutationen bei pustulöser Psoriasis) und entsprechende zielgerichtete Therapien entwickelt. Neutrophile Dermatosen sind von großer klinischer Bedeutung, da ihnen benigne oder maligne Erkrankungen zugrunde liegen können.
Abstract
This article reviews noninfectious inflammatory dermatoses with mainly neutrophilic infiltrates and the formation of pustules. The infiltrate containing neutrophils may either be mild as in urticaria or very dense, even with leukocytoclasia, as in Sweet syndrome or pyoderma gangrenosum. Neutrophilic infiltrates and pustular eruptions are caused by different noninfectious immunomechanisms. For some of them, mutations have been found (e.g. NLRC4 mutation in cryopyrin-associated periodic syndromes (CAPS) leading to activation of the inflammasome; IL36RN mutation in pustular psoriasis resulting in uncontrolled IL36 signaling). Neutrophilic dermatoses are of high interest, as they may be the cause of underlying benign or malignant conditions. In recent years, efficient targeted therapies have been developed.
Literatur
Baartman B, Kosari P, Warren CC et al (2014) Sight-threatening ocular manifestations of acute febrile neutrophilic dermatosis (Sweet’s syndrome). Dermatology 228(3):193–197
Bidyasar S, Montoya M, Suleman K, Markowitz AB (2008) Sweet syndrome associated with granulocyte colony-stimulating factor. J Clin Oncol 26(26):4355–4356
Brehler R, Reimann S, Bonsmann G, Metze D (1997) Neutrophilic hidradenitis induced by chemotherapy involves eccrine and apocrine glands. Am J Dermatopathol 19(1):73–78
Broekaert SM, Böer-Auer A, Kerl K et al (2016) Neutrophilic epitheliotropism is a histopathological clue to neutrophilic urticarial dermatosis. Am J Dermatopathol 38(1):39–49
Christophers E, Metzler G, Röcken M (2014) Bimodal immune activation in psoriasis. Br J Dermatol 170(1):59–65
Cohen PR (2009) Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 10(5):301–312
Cohen PR, Kurzrock R (2002) Sweet’s syndrome: a review of current treatment options. Am J Clin Dermatol 3(2):117–131
Dib EG, Ifthikharuddin JJ, Scott GA et al (2005) Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy. Leuk Res 29(2):233–234
Giasuddin AS, El-Orfi AH, Ziu MM, El-Barnawi NY (1998) Sweet’s syndrome: Is the pathogenesis mediated by helper T cell type 1 cytokines? J Am Acad Dermatol 39(6):940–943
Harrist TJ, Fine JD, Berman RS et al (1982) Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 118(4):263–266
Herms F, Franck N, Kramkimel N et al (2017) Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse event. Br J Dermatol 176(6):1645–1648
Imhof L, Meier B, Frei P et al (2015) Severe Sweet’s syndrome with elevated cutaneous interleukin-1β after azathioprine exposure: case report and review of the literature. Dermatology 230(4):293–298
Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784–790
Kieffer C, Cribier B, Lipsker D (2009) Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine 88(1):23–31
Magro CM, Momtahen S, Nguyen GH, Wang X (2015) Histiocytoid Sweet’s syndrome: a localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease. Eur J Dermatol 25(4):335–341
Marcoval J, Martín-Callizo C, Valentí-Medina F et al (2016) Sweet syndrome: long-term follow-up of 138 patients. Clin Exp Dermatol 41(7):741–746
Marini M, Wright D, Ropolo M (2002) Neutrophilic eccrine hidradenitis secondary to topotecan. J Dermatolog Treat 13(1):35–37
Marzano AV, Borghi A, Meroni PL, Cugno M (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 175(5):882–891
Marzano AV, Cugno M, Trevisan V et al (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162(1):100–107
Marzano AV, Ishak RS, Saibeni S et al (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202–210
McDermott MF, Aksentijevich I, Galon J et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97(1):133–144
Naim M, Weyers W, Metze D (2011) Histopathologic features of exanthematous drug eruptions of the macular and papular type. Am J Dermatopathol 33(7):695–704
Navarini AA, Burden AD, Capon F et al (2017) ERASPEN Network. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 31(11):1792–1799
Rochet NM, Chavan RN, Cappel MA et al (2013) Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol 69(4):557–564
Roujeau JC, Bioulac-Sage P, Bourseau C et al (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127(9):1333–1338
Satra K, Zalka A, Cohen PR, Grossman ME (1994) Sweet’s syndrome and pregnancy. J Am Acad Dermatol 30(2 Pt 2):297–300
Stahr BJ, Cooper PH, Caputo RV (1994) Idiopathic plantar hidradenitis: a neutrophilic eccrine hidradenitis occurring primarily in children. J Cutan Pathol 21(4):289–296
Strutton G, Weedon D, Robertson I (1995) Pustular vasculitis of the hands. J Am Acad Dermatol 32:192–198
Turan H, Kaya E, Gurlevik Z et al (2012) Neutrophilic eccrine hidradenitis induced by cetuximab. Cutan Ocul Toxicol 31(2):148–150
Broekaert SMC, Metze D (2016) Dermal entzündliche Dermatosen. In: Cerroni L, Garbe C, Metze D, Kutzner H, Kerl H (Hrsg) Histopathologie der Haut. Springer Reference Medizin. Springer, Berlin, Heidelberg, S 171–183
Möckel SMC, Metze D (2020) Neutrophilic and pustular eruptions. In: Hoang M, Selim M (Hrsg) Hospital-based dermatopathology. Springer, Cham, S 93–136
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. M. C. Möckel und D. Metze geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Schwerpunktherausgeber
T. Mentzel, Friedrichshafen
E. Bierhoff, Bonn
Rights and permissions
About this article
Cite this article
Möckel, S.M.C., Metze, D. Neutrophilenreiche und pustulöse Dermatitiden. Pathologe 41, 364–370 (2020). https://doi.org/10.1007/s00292-020-00784-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-020-00784-x